Iterum Therapeutics PLC Q1 2021 Earnings Call Transcript - Thomson StreetEvents

Iterum Therapeutics PLC Q1 2021 Earnings Call Transcript

Iterum Therapeutics PLC Q1 2021 Earnings Call Transcript - Thomson StreetEvents
Iterum Therapeutics PLC Q1 2021 Earnings Call Transcript
Published May 14, 2021
10 pages (6885 words) — Published May 14, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ITRM.OQ earnings conference call or presentation 14-May-21 12:30pm GMT

  
Brief Excerpt:

...Good morning, and welcome to Iterum Therapeutics' First Quarter 2021 Financial Results Conference Call. A press release with the company's first quarter results was issued earlier this morning and can be found on our website. We are joined this morning by Corey Fishman, CEO; and Judy Matthews, CFO. Corey will provide some opening remarks. Judy will provide details on our financial results, and then we'll open the lines for Q&A. Before we begin, I would just like to remind you that this call will contain forward-looking statements concerning our plans, strategies and prospects for our business, including with respect to the timing of review for the FDA of our NDA for oral sulopenem and related PDUFA date; the holding of an FDA Advisory Committee meeting to discuss the NDA; our expectations for potential approval on the PDUFA date; the market potential for sulopenem; commercialization activities, including the ability to enter into a definitive agreement with respect to commercialization...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Iterum Therapeutics PLC
Ticker
ITRM.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Gregory James Renza - RBC Capital Markets, Research Division - Analyst : Corey, just with respect, of course, with the regulatory actions in focus. I know we've kind of characterized this as a standard review. Just in light of the Ad Com status changing, I'm just curious if you could maybe opine a little bit on how you think the PDUFA date will play out. It sounds like it's currently scheduled, but do you have a sense of any reschedule or pushback in timing? And when would you expect to sort of get clarity there?

Question: Gregory James Renza - RBC Capital Markets, Research Division - Analyst : Yes, I can hear you.

Question: Gregory James Renza - RBC Capital Markets, Research Division - Analyst : That's great. Maybe just for my last question, I'll just zoom out a little bit. I'm just curious of your latest thoughts on sector interest in anti-infectives. There have been some strategic deals that have been occurring across the space. How do you see that evolving? You're certainly in a unique position with Iterum. But I'm just thinking of gathering your latest perspective on the anti-infective sector in general. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. MAY 14, 2021 / 12:30PM, ITRM.OQ - Q1 2021 Iterum Therapeutics PLC Earnings Call

Table Of Contents

Iterum Therapeutics PLC at SRAX Sequire Biotechnology Conference (Virtual) Transcript – 2023-02-02 – US$ 54.00 – Edited Transcript of ITRM.OQ presentation 2-Feb-23 7:30pm GMT

Iterum Therapeutics PLC Q3 2022 Earnings Call Transcript – 2022-11-10 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 10-Nov-22 1:30pm GMT

Iterum Therapeutics PLC Q4 2021 Earnings Call Transcript – 2022-03-28 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 28-Mar-22 12:30pm GMT

Iterum Therapeutics PLC Q3 2021 Earnings Call Transcript – 2021-11-12 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 12-Nov-21 1:30pm GMT

Iterum Therapeutics PLC Q2 2021 Earnings Call Transcript – 2021-08-13 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 13-Aug-21 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Iterum Therapeutics PLC Q1 2021 Earnings Call Transcript" May 14, 2021. Alacra Store. May 23, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2021-Iterum-Therapeutics-PLC-Earnings-Call-T14763809>
  
APA:
Thomson StreetEvents. (2021). Iterum Therapeutics PLC Q1 2021 Earnings Call Transcript May 14, 2021. New York, NY: Alacra Store. Retrieved May 23, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2021-Iterum-Therapeutics-PLC-Earnings-Call-T14763809>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.